FOSTER CITY, Calif. -- Sept. 29, 2021-- Mirum Pharmaceuticals, Inc. (Nasdaq: MIRM), a leader in rare liver disease, today announced that the U.S. Food and Drug Administration (FDA) has approved...
Jeff Collins will participate in the US-India BioPharma Summit (theme: "Delivering Affordable Innovation through Cross-Border Partnerships") in Cambridge, MA
News | 06. 13. 2008
